Arena Pharmaceuticals, Inc. (ARNA)

[clawmann]

They just finished responding to a CRL. That's what this adcom was about. And the FDA was very much in ARNA's corner at this adcom. Very different dynamic this year than 2010.

I don't think you know much about this company, lorcaserin, or their history with the FDA. Some of us have done a huge amount pf research. One of the more focused analysts just gave ARNA an upgrade and pegged its approval chances at 95%. I agree. June 27 this gets approved.

The bigger question mark hangs over VVUS and qnexa, not ARNA and lorcaserin.